Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).
| dc.contributor.author | García Pardo, Miguel | |
| dc.contributor.author | García de Herreros, Marta | |
| dc.contributor.author | Auclin, Edouard | |
| dc.contributor.author | Ferriol Galmes, Miquel | |
| dc.contributor.author | Laguna Egea, Juan Carlos | |
| dc.contributor.author | Gorría, Teresa | |
| dc.contributor.author | Caravaca, Gerard | |
| dc.contributor.author | Sart, Joan | |
| dc.contributor.author | Albarrán Artahona, Víctor | |
| dc.contributor.author | López Castro, Rafael | |
| dc.contributor.author | Teixidó Febrero, Cristina | |
| dc.contributor.author | Castellano, Giancarlo | |
| dc.contributor.author | Martínez Bedmar, Alex | |
| dc.contributor.author | Arcocha, Ainara | |
| dc.contributor.author | Alcolea, Laura | |
| dc.contributor.author | Jiménez, Manuel | |
| dc.contributor.author | Bernabeu, Mario | |
| dc.contributor.author | Delgado Cano, David | |
| dc.contributor.author | Navarro, Alejandro | |
| dc.contributor.author | Prat Aparicio, Aleix | |
| dc.contributor.author | Reguart, Noemí | |
| dc.contributor.author | Elio, Javier | |
| dc.contributor.author | Garrido, Pilar | |
| dc.contributor.author | Leighl, Natasha B. | |
| dc.contributor.author | Besse, Benjamin | |
| dc.contributor.author | Mezquita, Laura | |
| dc.date.accessioned | 2026-01-26T16:10:46Z | |
| dc.date.available | 2026-01-26T16:10:46Z | |
| dc.date.issued | 2025-06-26 | |
| dc.date.updated | 2026-01-26T16:10:46Z | |
| dc.description.abstract | Background: Geographical variations in the frequency of oncogenic driver alterations in non-small cell lung cancer (NSCLC) are observed worldwide, likely influenced by genetic and environmental factors. Radon, a leading cause of lung cancer in nonsmokers, may influence NSCLC's molecular profile. Objectives: This study aims to explore the potential correlation between estimated indoor radon concentrations and the frequency of driver alterations in NSCLC across Europe. Design: Ecological study of European countries with available data on indoor radon exposure (estimated mean levels and the proportion (%) of dwellings with concentrations >200 and >400 Bq/m3), and frequency of NSCLC actionable genomic alterations (EGFR, ALK) from PubMed articles and meeting abstracts with sample size >100 patients. Methods: We retrospectively analyzed NSCLC molecular data and radon exposure levels from European countries. Radon data, including the mean and proportion (%) of dwellings with concentrations >200 and >400 Bq/m3, were sourced from the European Commission Report 2005. NSCLC molecular alteration frequency (EGFR, ALK) was extracted from PubMed articles with sample sizes >100 patients. The correlation between molecular alteration frequencies and country-specific radon data were assessed. Results: Data on radon exposure and EGFR/ALK frequency were available for 21 European countries. Five countries had mean radon levels >100 Bq/m3, and eight countries had ⩾3% of dwellings with concentrations >400 Bq/m3. The median frequency of EGFR mutations and ALK fusions was 11.3% (range 7%-18.1%) and 4.1% (range 3.4%-12%), respectively. A positive correlation was found between estimated ALK-fusion frequency and the percentage of dwellings with >400 Bq/m3 (r = 0.72, p = 0.001). No correlation was found between EGFR mutation frequency and radon exposure. Conclusion: We found a positive correlation between estimated ALK fusion frequency in NSCLC and the proportion of dwellings exceeding 400 Bq/m3 radon exposure in 21 European countries. Further research is needed to explore the potential influence of radon and other environmental factors on NSCLC with driver alterations. | |
| dc.format.extent | 10 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 764306 | |
| dc.identifier.issn | 1758-8340 | |
| dc.identifier.pmid | 40585875 | |
| dc.identifier.uri | https://hdl.handle.net/2445/226172 | |
| dc.language.iso | eng | |
| dc.publisher | SAGE Publications | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1177/17588359251351449 | |
| dc.relation.ispartof | Therapeutic Advances In Medical Oncology, 2025, vol. 17 | |
| dc.relation.uri | https://doi.org/10.1177/17588359251351449 | |
| dc.rights | cc-by-nc (c) García Pardo, Miguel et al., 2025 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.source | Articles publicats en revistes (Medicina) | |
| dc.subject.classification | Càncer de pulmó | |
| dc.subject.classification | Radó | |
| dc.subject.classification | Genòmica | |
| dc.subject.other | Lung cancer | |
| dc.subject.other | Radon | |
| dc.subject.other | Genomics | |
| dc.title | Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study). | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1